Genflow Biosciences (STU:WQ5) Receivables Turnover : 0.00 (As of Jun. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Genflow Biosciences Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Genflow Biosciences's Revenue for the six months ended in Jun. 2024 was €0.00 Mil. Genflow Biosciences's average Accounts Receivable for the six months ended in Jun. 2024 was €0.00 Mil.

Genflow Biosciences Receivables Turnover Historical Data

The historical data trend for Genflow Biosciences's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genflow Biosciences Receivables Turnover Chart

Genflow Biosciences Annual Data

Trend

Dec21

Dec22

Dec23

Receivables Turnover

Genflow Biosciences Semi-Annual Data
	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Receivables Turnover	Get a 7-Day Free Trial			-	-	-	-	-

Competitive Comparison of Genflow Biosciences's Receivables Turnover

For the Biotechnology subindustry, Genflow Biosciences's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genflow Biosciences's Receivables Turnover Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Genflow Biosciences's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Genflow Biosciences's Receivables Turnover falls into.

Genflow Biosciences Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Genflow Biosciences's Receivables Turnover for the fiscal year that ended in Dec. 2023 is calculated as

	Receivables Turnover (A: Dec. 2023 )
=	Revenue	/	Average Total Inventories
=	Revenue (A: Dec. 2023 )	/ (	(Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )
=	0	/ (	(0	+	0)	/	1 )
=	0	/	0
=	N/A

Genflow Biosciences's Receivables Turnover for the quarter that ended in Jun. 2024 is calculated as

	Receivables Turnover (Q: Jun. 2024 )
=	Revenue	/	Average Total Inventories
=	Revenue (Q: Jun. 2024 )	/ (	(Accounts Receivable (Q: Dec. 2023 )	+	Accounts Receivable (Q: Jun. 2024 ))	/	count )
=	0	/ (	(0	+	0)	/	1 )
=	0	/	0
=	N/A

Genflow Biosciences (STU:WQ5) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

Genflow Biosciences Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Genflow Biosciences's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

Genflow Biosciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genflow Biosciences PLC (STU:WQ5) » Definitions » Receivables Turnover

Comparable Companies

Traded in Other Exchanges

GENFF:USA GENF:UK

Address

6 Heddon Street, London, GBR, W1B 4BT

Website

https://www.genflowbio.com

Genflow Biosciences PLC is a preclinical biotechnology company focused on developing innovative biological interventions aimed at tackling the effects of aging, potentially slowing or halting the aging process and reducing the incidence of age-related diseases and thereby increasing life span. The company is also focused on longevity and the development of therapies to counteract the effects of aging and diseases associated with age.

Genflow Biosciences Headlines

No Headlines